Voluntis: Initiation of Voluntis Stock Coverage by the Brokerage Firm Gilbert Dupont
01 März 2021 - 6:00PM
Business Wire
Regulatory News:
Voluntis (Paris:ALVTX) (Euronext Growth Paris, Ticker: ALVTX -
ISIN: FR0004183960), a leader in the field of digital therapeutics,
announces that the brokerage firm Gilbert Dupont, a leading player
in the intermediation and financial operations segment, has just
initiated coverage of the company with a study entitled "Algorithms
enabling better care ".
This coverage aims to increase Voluntis' visibility, broaden its
investor base and enrich the consensus of financial analysts who
already track the stock alongside brokerage firm Bryan Garnier.
Gilbert Dupont initiates the coverage of the stock with a BUY
recommendation and a €8.9 target price.
Next meeting: publication of the 2020
annual results on March 30, 2021, after the close of trading.
About Voluntis
Voluntis creates digital therapeutics that empower people with
chronic conditions to self-manage their treatment every day, thus
improving real-world outcomes. Voluntis’ solutions, combining
mobile and web apps, use clinical algorithms to deliver
personalized recommendations to patients and their care teams. For
example, these recommendations are used to adjust treatment dosage,
manage side effects or monitor symptoms.
Leveraging its Theraxium technology platform, Voluntis has
designed and operates multiple digital therapeutics, especially in
oncology and diabetes. Voluntis has long-standing partnerships with
leading life science companies. Based in Cambridge, MA, and Paris,
France, Voluntis is a founding member of the Digital Therapeutics
Alliance.
For more information, please visit: www.voluntis.com
Mnemo : ALVTX - ISIN : FR0004183960
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210301005599/en/
ACTUS Media relations Vivien Ferran vferran@actus.fr +33 (0)1 53 67 36 34
ACTUS Investor relations Jérôme Fabreguettes-Leib
voluntis@actus.fr +33 (0)1 53 67 36
78
Voluntis Chief Financial Officer Guillaume Floch
investisseurs@voluntis.com +33 (0)1 41 38 39 20